Předmět: |
|
Zdroj: |
Gene Therapy Weekly; 7/3/2023, p684-684, 1p |
Abstrakt: |
Keywords: Guangzhou; People's Republic of China; Asia; Acute Lung Injury; Biotechnology; Connective Tissue Cells; Drugs and Therapies; Emerging Technologies; Engineering; Health and Medicine; Immunology; Lung Diseases and Conditions; Lung Injury; Macrophages; Mononuclear Phagocyte System; Myeloid Cells; Nanosystems; Nanotechnology; Phagocytes; Respiratory Tract Diseases and Conditions; Therapy EN Guangzhou People's Republic of China Asia Acute Lung Injury Biotechnology Connective Tissue Cells Drugs and Therapies Emerging Technologies Engineering Health and Medicine Immunology Lung Diseases and Conditions Lung Injury Macrophages Mononuclear Phagocyte System Myeloid Cells Nanosystems Nanotechnology Phagocytes Respiratory Tract Diseases and Conditions Therapy 684 684 1 07/03/23 20230703 NES 230703 2023 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Researchers detail new data in Lung Diseases and Conditions - Acute Lung Injury. Softer PSLipos-L-NAC could resist macrophage capture, but remarkably prolong their targeting effect period on macrophages via durable binding to macrophage surface, and subsequently more effectively suppress inflammatory response in macrophages and then hasten inflammatory lung epithelial cell wound healing. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|